Evidence map›Paper›PMID 20380481›Full record

ArticleAIDS research and human retroviruses2010

Alterations in natural killer cell receptor profiles during HIV type 1 disease progression among chronically infected South African adults.

Ambrose H W Wong, Katie Williams, Sharon Reddy, Douglas Wilson, Janet Giddy, Galit Alter, Musie Ghebremichael, Mary N Carrington, Thumbi Ndung'u, Bruce D Walker and 2 more

Open access · greenAbstract read
In one paragraph

Article in AIDS research and human retroviruses, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 29 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Article
  10. Immunogenetics of HIV disease.Immunological reviews · 2013
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 2 countries.

Ambrose H W WongRagon Institute of MGH, MIT, and Harvard (formerly Partners AIDS Research Center), Massachusetts General Hospital, Charleston, Massachusetts 02129, USA.
Katie Williams
Sharon Reddy
Douglas Wilson
Janet Giddy
Galit Alter
Musie Ghebremichael
Mary N Carrington
Thumbi Ndung'u
Bruce D Walker
Marcus Altfeld
William H Carr
University of KwaZulu-Natal · ZAAIDS United · USScience Applications International Corporation (United States) · US

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI Daniel Lingwood · 2004 to 2026
$94.4M
Effects of genetic polymorphism in MHC, KIR, and related loci on human diseaseZIABC010791 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI CARRINGTON, MARY N. · 2009 to 2025
$18.2M
AIDS-Restrictive Innate Immune MechanismsK01TW007793 · FIC · MASSACHUSETTS GENERAL HOSPITAL · PI CARR, WILLIAM H · 2008 to 2011
$489k
FIC NIH HHS K01-TW007703-01A1FIC NIH HHS K01 TW007793Intramural NIH HHSNCI NIH HHS HHSN261200800001ENIAID NIH HHS P30 AI060354PHS HHS R01-A1067031
6 · The paper itself

Abstract

Recent studies suggest that innate immune responses by natural killer (NK) cells play a significant role in restricting human immunodeficiency virus type-1 (HIV-1) pathogenesis. Our aim was to characterize changes in NK cells associated with HIV-1 clade C disease progression. Here we used multiparametric flow cytometry (LSRII) to quantify phenotype and function of NK cells in a cross-sectional analysis of cryopreserved blood samples from a cohort of 41 chronically HIV-1-infected, treatment-naive adult South Africans. These individuals ranged in disease severity from early (CD4 count >500) to advanced HIV-1 disease (CD4 count <50). We found that the frequency of NK cells expressing KIR2DL1, an inhibitory receptor, and/or KIR2DS1, an activating receptor, tended to decrease with increasing HIV-1 viral load. We also discovered a significant increase (p < 0.05) in overall NK cell degranulation with disease progression. We found that acutely activated NK cells (CD69(pos)) were deficient in NKp46 expression ex vivo. In conclusion, we observed that with viremia and advanced HIV-1 disease, activated NK cells lack NKp46 expression, and KIR2DS1(pos) and/ or KIR2DL1(pos) NK cells are reduced in frequency. These findings suggest that modulation of receptor expression on NK cells may play a role in HIV-1 pathogenesis, and provide new insights on immunological changes in advanced HIV-1 disease.

Indexed as

Disease ProgressionAdultCell DegranulationCross-Sectional StudiesFlow CytometryHIV-1HIV InfectionsHumansImmunity, InnateKiller Cells, NaturalNatural Cytotoxicity Triggering Receptor 1Receptors, KIRReceptors, KIR2DL1Receptors, Natural Killer CellSouth AfricaViral LoadKIR2DL1 protein, humanKIR2DS1 protein, humanNatural Cytotoxicity Triggering Receptor 1NCR1 protein, humanReceptors, KIRReceptors, KIR2DL1Receptors, Natural Killer Cell

Identifiers

PMID20380481
PMCPMC3111148
OpenAlexW2067165659

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.